Department of Kidney and Pancreas Transplantation, Tianjin First Central Hospital, Nankai District, Tianjin, 300192, China.
BMC Nephrol. 2023 Oct 13;24(1):303. doi: 10.1186/s12882-023-03358-0.
The prevalence of frailty among candidates and recipients of kidney transplantation (KT) is well-established, yet the impact of frailty on clinical outcomes following KT remains uncertain. To address this knowledge gap, we conducted a systematic meta-analysis to comprehensively assess the aforementioned relationship.
The present study conducted a comprehensive search of PubMed, Embase, and Cochrane Library databases to identify relevant observational studies that compared mortality risk and other clinical outcomes of KT recipients with and without frailty. Two authors independently conducted data collection, literature searching, and statistical analysis. The results were synthesized using a heterogeneity-incorporating random-effects model.
In this meta-analysis, 6279 patients from 13 cohort studies were included, and 1435 patients (22.9%) were with frailty before KT. There were higher mortality rates among frail patients at admission, compared to those without frailty (risk ratio [RR]: 1.97, 95% confidence interval [CI]: 1.57 to 2.47, p < 0.001; I = 19%). Subgroup analysis suggested the association between frailty and high mortality risk after KT was consistent in studies of frailty assessed via Physical Frailty Phenotype or other methods, and in studies of follow-up duration < or ≥ 5 years. In addition, frailty was associated with higher incidence of delayed graft function (RR: 1.78, 95% CI: 1.21 to 2.61, p = 0.003; I = 0%), postoperative complications (RR: 1.88, 95% CI: 1.15 to 3.08, p = 0.01; I = 0%), and longer hospitalization (RR: 1.55, 95% CI: 1.22 to 1.97, p < 0.001; I = 0%).
Following KT, frail patients are at higher risks for all-cause mortality, delayed graft function, postoperative complications, and longer hospital stays.
衰弱在接受肾移植(KT)的候选人和受者中很常见,但衰弱对 KT 后临床结局的影响尚不确定。为了填补这一知识空白,我们进行了系统的荟萃分析,全面评估了上述关系。
本研究全面检索了 PubMed、Embase 和 Cochrane 图书馆数据库,以确定比较 KT 受者和无衰弱患者死亡率和其他临床结局的观察性研究。两名作者独立进行数据收集、文献检索和统计分析。使用包含异质性的随机效应模型综合结果。
本荟萃分析纳入了来自 13 项队列研究的 6279 名患者,其中 1355 名(22.9%)患者在 KT 前存在衰弱。与无衰弱患者相比,入院时衰弱患者的死亡率更高(风险比 [RR]:1.97,95%置信区间 [CI]:1.57 至 2.47,p<0.001;I=19%)。亚组分析表明,通过身体虚弱表型或其他方法评估虚弱与 KT 后高死亡率风险之间的关联在随访时间<或≥5 年的研究中是一致的。此外,虚弱与延迟移植物功能(RR:1.78,95%CI:1.21 至 2.61,p=0.003;I=0%)、术后并发症(RR:1.88,95%CI:1.15 至 3.08,p=0.01;I=0%)和更长的住院时间(RR:1.55,95%CI:1.22 至 1.97,p<0.001;I=0%)的发生率较高相关。
在 KT 后,虚弱患者的全因死亡率、延迟移植物功能、术后并发症和住院时间较长的风险较高。